Latest Diamedica News & Updates
See the latest news and media coverage for Diamedica. We track all announcements, press releases, and industry mentions in real time, all in one place.
Safe anaesthesia and respiratory solutions for limited-resource settings
diamedica.co.uk- Headquarters
- Barnstaple, United Kingdom
- Company type
- Private company
- Number of employees
- 5–10
Latest news about Diamedica
Company announcements
-
Diamedica showcases DPA03 at WFSA Congress
The device supports disaster relief, emergency response, and rural healthcare. Strong interest draws visitors to their booth.
-
Diamedica launches handheld ultrasonic oxygen analyser for 2026
It measures oxygen in medical gas supplies. In LMICs, it protects patient safety, maximises resources, supports reliable care, and is cost-effective.
-
Diamedica announces Halothane production ceases
Vaporisers labelled for Halothane or Halothane/Isoflurane work with Isoflurane due to similar vapour pressures. Higher settings needed as Isoflurane is less potent.
-
Diamedica supplies emergency medical equipment for Ukraine aid
Diamedica provides portable anaesthetic machines, ventilator, and oxygen concentrator for a mobile hospital near Odesa. Dr. Andrey Varvinskiy praises their generosity and support.
Media coverage
-
DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke (AIS...
-
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2025 earnings call transcript
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2025 Earnings Call Transcript March 31, 2026 Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full...
-
DiaMedica Therapeutics Achieves Significant Progress Across Pipeline, Highlights Positive Interim Results for Preeclampsia Program
DiaMedica Therapeutics recently concluded a productive year across its pipeline, achieving key milestones and delivering promising results. The company's President and Chief Executive Officer, Rick...
-
DiaMedica reiterates plan for ReMEDy2 interim analysis in 2H 2026 as stroke trial approaches 70% of 200 patients
Management reiterated stroke timing, with Chief Medical Officer Julie Krop stating, "we are reiterating our guidance to complete the interim analysis by the second half...
Track Diamedica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group
FAKRO